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This methodological study aimed to adapt the Neuropathy - and Foot Ulcer - Specific Quality of 
Life instrument - NeuroQol to Brazilian Portuguese and to analyze its psychometric properties. 
Participants were 50 people with peripheral diabetic neuropathy and foot ulcers. The floor 
and ceiling effects, the convergent and discriminant validity and the reliability were analyzed. 
The Cronbach’s alpha coefficient was used to test the reliability and the Pearson’s correlation 
coefficient to estimate the convergent validity, the Student’s t test was used to evaluate the 
discriminant validity in the comparison of the NeuroQol scores between participants with and 
without ulcers. Floor and ceiling effects were found in some domains of the NeuroQol. The 
reliability was satisfactory. The correlations between the domains of the NeuroQol and the SF-
36 were negative, significant and of moderate to strong magnitude. The findings show that the 
Brazilian version of the NeuroQol is reliable and valid and may be employed as a useful tool for 
improving nursing care for people with DM.
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Adaptação cultural e validação do Neuropathy - and Foot Ulcer - Specific 
Quality of Life (NeuroQol) para a língua portuguesa do Brasil - Fase 1
Trata-se de estudo metodológico que teve como objetivos adaptar o Neuropathy - and 
Foot Ulcer - Specific Quality of Life - NeuroQol para a língua portuguesa do Brasil, e 
analisar suas propriedades psicométricas. Participaram 50 pessoas com neuropatia 
diabética periférica e úlceras nos pés. Foram analisados os efeitos floor e ceiling, a 
validade convergente, a discriminante e a confiabilidade. Foi utilizado o coeficiente alfa 
de Cronbach para testar a confiabilidade e o de correlação de Pearson para estimar 
a validade convergente; o teste t-Student foi empregado para avaliar a validade 
discriminante, na comparação dos escores do NeuroQol entre os participantes com e 
sem úlceras. Constataram-se efeitos floor e ceiling em alguns domínios do NeuroQol. 
A confiabilidade foi satisfatória. As correlações entre os domínios do NeuroQol e SF-36 
foram negativas, significativas, de moderada a forte magnitude. Os achados evidenciam 
que a versão brasileira do NeuroQol é confiável e válida, e que ele poderá ser utilizado 
como ferramenta útil para melhoria da assistência de enfermagem para as pessoas 
com DM.
Descritores: Diabetes Mellitus; Estudos de Validação; Qualidade de Vida; Neuropatias 
Diabéticas; Pé Diabético.
Adaptación cultural y validación del Neuropathy - and Foot Ulcer - 
Specific Quality of Life (NeuroQol) para el idioma portugués de Brasil 
- Fase 1
Estudio metodológico que tuvo como objetivos adaptar el Neuropathy - and Foot Ulcer 
- Specific Quality of Life - NeuroQol para el idioma portugués de Brasil y analizar sus 
propiedades psicométricas. Participaron 50 personas con neuropatía diabética periférica 
y úlceras en los pies. Fueron analizados los efectos floor y ceiling, la validez convergente, 
la discriminante y la confiabilidad. Fue utilizado el coeficiente alfa de Cronbach para 
comprobar la confiabilidad y la correlación de Pearson para estimar la validez convergente; 
el test t-Student fue empleado para evaluar la validez discriminante en la comparación de 
los puntajes del NeuroQol entre los participantes con y sin úlceras. Se constataron  efectos 
floor y ceiling en algunos dominios del NeuroQol. La confiabilidad fue satisfactoria. Las 
correlaciones entre los dominios del NeuroQol y SF-36 fueron negativas, significativas, 
de moderada a fuerte magnitud. Los hallazgos evidencian que la versión brasileña del 
NeuroQol es confiable y válida y podrá ser utilizado como una herramienta útil para la 
mejoría de la asistencia de enfermería para las personas con DM.
Descriptores: Diabetes Mellitus; Estudios de Validación; Calidad de Vida; Neuropatías 
Diabéticas; Pie Diabético.
Introduction
nine years, a study conducted in the city of Ribeirão 
Preto-SP, using similar methods, indicated a prevalence 
of 12.1%(3). A recent study(4), performed in the same city 
in 2006, showed a prevalence of 15.02%. Associated 
with the increased prevalence of DM there was also 
an increase in the number of people with chronic DM 
Diabetes mellitus (DM) has emerged among 
the chronic degenerative diseases due to its growing 
prevalence and the increased morbidity and mortality 
associated with the disease(1). The prevalence of DM in 
the urban population, in the age group 30 to 69 years, 
from 1986 to 1988 was 7.6%(2) and after approximately 
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complications and of premature deaths, mainly from 
cardiovascular disease(5).
The chronic hyperglycemia of diabetes is 
associated with long-term damage, dysfunction and 
failure of various organs, especially the eyes, kidneys, 
nerves, heart and blood vessels(6). In the context of 
the morbidities associated with DM, Diabetic Peripheral 
Neuropathy (DPN) is one of the chronic complications 
of high prevalence, affecting 60% of people with 
Diabetes Mellitus, and is considered the most important 
precursor of plantar ulcers and amputations of feet in 
this group of people(7-8). The neurological dysfunction 
starts in the distal portions of the peripheral nervous 
system (usually the feet) and can extend to the upper 
limbs(9). The impairment of the motor nerves of the 
lower limbs in people with DM determines muscular 
hypotrophy, deformities and abnormal pressure points; 
the impairment of the sensory nerves manifests as 
sensitivity of the extremities and can progress to 
anesthesia(10).
The clinical manifestations associated with 
DPN, as well as its main consequences (ulcers and 
amputations of the lower limb extremities) may 
compromise the quality of life (QoL) of people with 
DM(11). Therefore, the development of an instrument to 
evaluate the Health-Related Quality of Life (HRQoL) of 
people with DM and neuropathy evidences, by means 
of its domains (pain, loss/reduction of sensitivity, 
diffuse sensory-motor symptoms, limitations in daily 
activities, interpersonal problems and emotional 
distress), the factors that could jeopardize the HRQoL, 
specifically of these people(12).
The evaluation of HRQoL directed toward health 
problems, such as DPN among people with DM, is 
essential to identify the needs and specific interventions 
and, therefore, to promote effective solutions to 
minimize injuries and to prevent future ones. However, 
studies evaluating HRQoL focused on the effects of 
DPN are still incipient(13) and, in the national literature, 
do not identify specific instruments for this purpose. 
Therefore, when considering DPN as a complication of 
severe morbidity, the need becomes clear to provide 
a specific measure of HRQoL for people with DM, DPN 
and foot ulcers. Thus, the aim of this study was to 
perform the adaptation of the NeuroQol - Neuropathy - 
and Foot Ulcer - Specific Quality of Life instrument for 
the Brazilian Portuguese language, as well as to test 
the reliability and validity of the Brazilian version when 
used on people with DM in the presence of DPN and 
foot ulcers.
Methods
This methodological adaptation and validation study 
of the instrument NeuroQol(12), considered the first phase 
of the validation process, consists of the initial analysis 
of the psychometric properties of the adapted version. 
It was developed in two steps, the cultural adaptation 
and the verification of the initial psychometric properties 
of the instrument. The NeuroQol is a multidimensional 
scale, developed in the UK and the USA, composed 
of 35 items. Of these, 27 items evaluate the HRQoL 
in relation to six domains of the life of a person: Pain 
(seven items), loss/reduction of sensitivity (three 
items), diffuse sensory-motor symptoms (three items), 
limitations in daily activities (three items), interpersonal 
problems (four items), and emotional distress (seven 
items). There is one item at the end of each domain, 
which evaluates, in general, the effects of the domain 
on HRQoL (items A, B, C, D, E and F), totaling six items. 
There are also two final items in the scale that evaluate, 
respectively, the impact of foot problems on HRQoL and 
the general classification of the HRQoL.
The NeuroQol allows people to respond with the 
frequency of the symptoms or how the foot problems 
have affected their HRQoL over the previous four weeks, 
marking an X on the scale of one to five. Depending 
on the type of question, the number one represents a 
“never or hardly at all”, and the number five “all of the 
time or a lot, such as exemplified below. After marking 
the response to a particular item, the participants were 
asked to also mark how much the contents of that item 
represents a discomfort or how important it is, on a scale 
of one to three, with a response of 1=not at all, 2=a 
little, and 3=a lot(12). To obtain the weighted scores for 
each item of the respective domains, the value obtained 
on each item (1-5) is multiplied by the value assigned 
to the corresponding discomfort/importance (1-3). This 
multiplication provides the degree of impact of the items 
which compose the instrument. The total values  of the 
scores in each domain are calculated by the mean of the 
weighted items of the respective domains and can vary 
from 1 to 15, i.e. the highest value corresponds to a 
reference of poor HRQoL.
Step 1: Adaptation of the instrument
For the adaptation study of the instrument, 
authorization was requested from the authors(12) of the 
original version, following the methodological steps(14) 
that comprise the translation into the target language, 
i.e. the assessment of this version by a Committee 
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of Judges for evaluation of the semantic, idiomatic, 
conceptual and cultural equivalence, the backtranslation 
for the analysis of the authors of the instrument and, 
finally, the semantic analysis with 18 people from the 
target population who were not part of the sample 
studied.
The translation was performed by two Brazilians, 
one an English Language teacher and one that works 
in the area of translation of health issues, after being 
informed about the aims of the study. This step resulted 
in two versions in Portuguese: called the translated 
Portuguese versions, TPV1 and TPV2. The translated 
Portuguese versions were compared by the researchers 
in order to select the phrases of best expression and, as 
a result of this step, a consensus version was created 
in Portuguese called Consensual Portuguese Version 
1 (CPV1). The next step was the backtranslation, 
performed by two independent translators, fluent in 
English, to create the American English version. These 
translators were not aware of the objectives of the study 
and were not familiar with the original version of the 
instrument. Each produced an English version, called 
the English Version 1 and English Version 2, (EV-1 and 
EV-2). After the creation of the versions there was a 
meeting with the translators and one of the researchers, 
where the aims of the study were presented, the two 
versions compared and a Final English Version (FEV) of 
the instrument obtained. Following this a copy of the 
original instrument was given to each of the translators, 
to make comparisons with FEV. At this point, each 
part of the instrument (instructions, items and scale 
of responses) was read, and the translations made 
were evaluated seeking one that was more appropriate 
regarding the conceptual and cultural equivalence, 
thus resulting in the Consensual Portuguese Version 
3 (CPV-3). After completion of these steps, the Final 
English Version was sent, via e-mail, to the principle 
author of the instrument, to evaluate the retroversion 
of the instrument. The author was in agreement and, 
therefore, it was possible to continue to the next stages 
of the study.
The Brazilian version was submitted to semantic 
analysis, evaluated by 18 people with DM. From a 
committee of specialists (five of them working in the 
areas of diabetes mellitus, one in the area of  diabetic 
ulcers, one in the area of  measurement instruments and 
one in the area of  quality of life; a bilingual translator 
and a person with DM and higher education) the 
evaluation of semantic, idiomatic, cultural and conceptual 
equivalence of each item was requested. The judges 
made semantic adaptations from English to Brazilian 
Portuguese, allowing for the appropriateness of use in 
Brazil. Following this evaluation of the revised version, 
the instructions of the instrument were modified, along 
with other minimal changes related to the placement 
of prepositions before each item of the instrument 
(by, at). This last version was submitted to semantic 
analysis(15), which enabled the detection of difficulty 
in understanding the item “Do you have a paid job?” 
which was modified to “Do you receive wages for your 
work?” and became comprehensible after reapplication. 
Overall, the instrument was easily comprehended by the 
participants in the semantic analysis and there were no 
other changes suggested.
Step 2: Verification of the initial psychometric 
properties of the instrument
In this step, between October 2009 to May 2010, 
50 people(16) in followed up at the Diabetes Outpatient 
Clinic of a Teaching Hospital and Teaching Health Center 
in São Paulo State, responded to the instrument. People 
were included with diabetes mellitus type 1 (DM1) or 
diabetes mellitus type 2 (DM2), who had DPN or foot 
ulcers, of both sexes, aged over 18 years, with no 
other advanced-stage chronic complications and with 
the cognitive ability to respond to the questions of the 
instrument.
To test the convergent validity, the instrument used 
was “Perceived Health Status” (SF-36) (Medical Outcomes 
Study 36 - Item Short-Form Health Survey)(17), in its 
version adapted to Portuguese(18) and to assess the 
validity, two distinct groups were formed: one group 
of people with ulcers and the other without ulcers. The 
diagnosis of DPN was by electromyography, performed 
by the neurology physician. The people with foot ulcers 
were identified through the follow-up appointment 
records of their respective units. The participants 
responded to the Brazilian versions of the NeuroQol 
and the SF-36(18), at the same time, through individual 
interviews. Information on the sociodemographic and 
clinical characteristics of the people were also collected 
through interviews and consultation with the medical 
records of the participants. Those excluded were people 
with other comorbidities that could contribute to the 
development of neuropathy, such as hypothyroidism, 
alcoholism, and leprosy, among others; people with 
diabetes who presented at least one of the following 
conditions: undergoing hemodialysis, blindness, 
presence of sequelae of cerebral vascular accident/
heart failure, previous amputations at any level of the 
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lower limb, presence of other disabling complications; 
and people with difficulties of comprehension of the 
instruments due to cultural factors.
Statistical procedures
For the construct validity convergent and 
discriminant analyses were employed. In the convergent 
analysis it was chosen to investigate the relationship 
between the domains of the NeuroQol and those of 
the SF-36, since these instruments evaluate similar 
constructs, although with opposite scores, i.e. higher 
values  obtained in the NeuroQol indicate a greater 
impact of the neuropathy and ulcer on the HRQoL, while 
higher scores with the application of the SF-36 indicate a 
better HRQoL. Therefore, negative correlations between 
the domains of these instruments were expected.
The areas evaluated in the SF-36 are: Functional 
Capacity - FC (ten items), Physical Aspects - PA (four 
items), Pain - P (two items), General Health Status - GHS 
(five items), Vitality - VIT (four items), Social Aspects - 
SA (two items), Emotional Aspects - EA (three items), 
Mental Health -MH (five items) and one general question 
of comparative evaluation between the current general 
health status and that of one year before. The first four 
domains (FC, PA, P and GHS) evaluate the physical health, 
and the last four (VIT, SA, EA and MH) the mental health. 
This separation into two major components, physical and 
mental, allowing the generic analysis of the two aspects 
involved, which may present themselves distinctly 
in diverse pathologies(18). To obtain the scores, the 
questions should be scored according to predetermined 
rules. Subsequently, the values of the questions are 
transformed into scores of eight domains which range in 
the scale from zero to 100, where zero corresponds to the 
worst health status and 100 the best(18).
The analysis of the relationship between the domains 
of NeuroQol and the Physical and Mental components of 
the SF-36 (convergent analysis) was carried out using 
Pearson’s linear correlation test, and the results were 
analyzed according to the following classification: 0.00 
to 0.19 - absent or very weak correlation; 0.20 to 0.39 
- weak correlation; 0.40 to 0.59 - moderate correlation; 
0.60 to 0.79 - strong correlation; 0.80 to 1.00 - very 
strong correlation(19). For the Discriminant Construct 
Validity, initially the normality of distribution of the 
sample means of the scores for each domain of the 
groups with ulcers and without ulcers was tested using 
the Kolmogorov-Smirnov test (KS). After confirmation of 
the normality, the Student’s t-test was used to compare 
the means of the instrument between the with ulcer and 
without ulcer groups. The reliability of the instrument, 
with regard to the internal consistency of the items, was 
estimated by Cronbach’s coefficient alpha, considering 
values  between 0.70 and 0.90 to be adequate(20). The 
presence of floor and ceiling effects were also verified. 
These occur when more than 15% of the respondents 
are concentrated in the minimum or maximum value of 
the scale(16).
The project was approved by the Research Ethics 
Committee of Clinical Hospital and Teaching Health 
Center of the School of Medicine of Ribeirão Preto, 
University of São Paulo, with permission to access the 
medical records archive service. All the subjects who 
agreed to participate in the study signed the Terms of 
Free Prior Informed Consent, in duplicate.
Results
Due to the inclusion/exclusion criteria established, 
the time available for data collection and the need to 
conduct an examination to confirm the neuropathy, it 
was not possible to increase the sample size. Therefore, 
the study sample was composed of 50 people. Among 
the 50 participants, 18 (54%) were female. Ages ranged 
from 29 to 72 years, with a mean of 55.7 (10.1) years 
and a median of 56 years. With regard to the level of 
schooling, low levels of schooling were found (70.6%). 
When analyzing the duration of DM among participants, 
a mean of 16.3 (8.2) years of existing with the disease 
was found. With respect to the body mass index (BMI) 
of the sample, 78.4% were in the overweight and obese 
categories. The participants of this study showed a mean 
of fasting plasma glucose of 184 mg/dL, and of glycated 
hemoglobin of 9.9%.
In the description of the scores obtained in the 
responses to the adapted instrument, for the total 
measure a mean score of 7.2 (5.2) was obtained, which 
could vary from 1 to 15. The domain that obtained the 
highest mean value was Limitations in daily activities, 
with 9.9 (4.3), while the lowest was in the domain Pain, 
with 5.8 (2.6). Regarding the reliability of the adapted 
version of the NeuroQol, evaluated with the Cronbach’s 
alpha, the value for the total instrument was 0.94. The 
Cronbach’s alpha values in the domains ranged from 0.64 
(Pain) to 0.89 (Limitations in daily activities) (Table 1).
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Table 1 - Number of items, range obtained, mean, median and Cronbach’s coefficient alpha of the NeuroQol domains 
and of the total score for the study sample (n=50). Ribeirão Preto, SP, Brazil, 2010
Domains of the NeuroQol No. of items
Range obtained for the 
mean score Median Mean (sd)* Cronbach’s alpha
(Min - Max)
NeuroQol total 35 1–15 6.8 7.2 (5.2) 0.94
Pain 7 1–12 5.5 5.8 (2.6) 0.64
Loss/reduction in sensitivity 3 1–15 7.1 7.3 (4.8) 0.76
Diffuse sensory-motor symptoms 3 1–15 8.6 7.6 (4.4) 0.70
Limitations in daily activities 3 1–15 12.0 9.9 (4.3) 0.89
Interpersonal problems 4 1–14 6.2 6.7 (3.9) 0.86
Emotional distress 7 1–15 8.4 7.9 (4.6) 0.88
*sd: standard deviation
Table 2 - Item-total correlation coefficients and Cronbach’s alpha for the items of the NeuroQol when each of the 
items was excluded. Ribeirão Preto, SP, Brazil, 2010
The evaluation of the internal consistency of the 
items in each domain of the NeuroQol, through the 
Cronbach’s alpha coefficient, obtained values  greater 
than 0.93. The Pearson’s product moment correlation 
test was used to verify the intercorrelations between 
each item of the instrument, with the total of the scale, 
and the alpha values,  when each item was excluded, i.e. 
analysis of the extent of the negative or positive impact 
of the Cronbach’s Coefficient on the performance of the 
scale (Table 2).
NeuroQol (α total=0.94)
Item-total 
Correlation
Cronbach’s alpha
if item excluded
1. Burning in your legs or feet. 0.84 0.947
2. Excessive heat or cold in your legs or feet. 0.47 0.944
3. Pins and pricks in your legs or feet. 0.40 0.944
4. Acute or piercing pain in your legs or feet. 0.35 0.945
5. Pounding in your legs or feet. 0.43 0.944
6. Feelings in your legs or feet that make them jump. 0.47 0.944
7. Skin irritation caused by something in contact with your feet, sheets or socks, for example. 0.10 0.947
A. Have these painful symptoms diminished your quality of life? 0.87 0.946
8. Numbness in your feet. 0.83 0.940
9. Inability to feel the difference between hot and cold with your feet 0.77 0.940
10. Inability to feel objects with your feet. 0.66 0.942
B. Have these last three symptoms diminished your quality of life? 0.85 0.946
11. Weakness in your hands. 0.45 0.944
12. Balance problems or instability when walking. 0.51 0.943
13. Balance problems or instability when standing. 0.50 0.943
C. Have these last three symptoms diminished your quality of life? 0.74 0.946
14. Ability to do your job. 0.74 0.941
15. Ability to do housework or to garden. 0.66 0.942
16. Ability to participate in leisure activities. 0.67 0.941
D. Have these changes in your daily activities, as a consequence of your foot problems, diminished your 
quality of life?
0.87 0.946
17. To what extent have your foot problems interfered in your relationships with people close to you? 0.84 0.940
18. Did you feel more physically dependent than you would like to on people who are close to you as a 
consequence of your foot problems?
0.61 0.942
19. Did you feel more emotionally dependent than you would like to on people who are close to you as a 
consequence of your foot problems?
0.53 0.943
20. Has your role in the family changed as a result of your foot problems? 0.63 0.942
E. Have these changes in your relationships with other people, as a consequence of your foot problems, 
diminished your quality of life?
0.76 0.946
21. People treat me differently from others persons because of my foot problems. 0.70 0.941
(continue...)
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Table 3 - Floor and ceiling effects in the responses in the domains of the NeuroQol. Ribeirão Preto, SP, Brazil, 2010
Table 4 - Pearson correlation coefficients between the 
domains of the NeuroQol instrument and the components 
of the SF-36. Ribeirão Preto, SP, Brazil, 2010
NeuroQol (α total=0.94)
Item-total 
Correlation
Cronbach’s alpha
if item excluded
22. I feel older than I really am because of my foot problems. 0.69 0.941
23. My self-confidence is affected because of my foot problems. 0.49 0.944
24. My foot problems turn my life into a struggle. 0.86 0.939
25. I generally feel frustrated because of my foot problems. 0.91 0.938
26. My foot problems make me feel constrained. 0.85 0.939
27. I feel depressed because of my foot problems. 0.84 0.939
F. Have these feelings about yourself, because of your foot problems, diminished your quality of life? 0.73 0.946
28. In general, I would say that my foot problems diminished my quality of life. 0.80 0.946
29. In general, I would rate my quality of life as -0.82 0.950
Table 2 - continuation
The descriptive results of the Brazilian version of the 
NeuroQol also allowed the evaluation of the concentration 
of the responses between the participants, which verified 
the floor and ceiling effects in the sample studied. It 
was observed that in the domains Loss/reduction of 
sensitivity and Limitations in daily activities, there was a 
floor and ceiling effect, respectively (Table 3).
Domains of the NeuroQol
Adapted NeuroQol Original NeuroQol 
% responses % responses % responses % responses
Pain 2.0 2.0 14.4 0.5
Loss/reduction in sensitivity 16.0 8.0 20.4 19.0
Diffuse sensory-motor symptoms 10.0 8.0 25.5 4.4
Limitations in daily activities 4.0 22.0 28.4 8.3
Interpersonal problems 2.0 4.0 28.4 8.3
Emotional distress 4.0 4.0 20.7 1.0
The evaluation of convergent construct validity 
was verified by the correlation between the NeuroQol 
scores and the physical and mental components of the 
SF-36. While the lower SF-36 instrument values  reflect 
a poorer perception of the general health status, in the 
NeuroQol lower values  indicate better QoL. The Pearson 
correlation coefficients between the measures are 
presented in Table 3. Negative, statistically significant 
linear correlations were found of moderate magnitude 
between the domains Pain and the Mental component 
(r=-0.41; p<0.01); Loss/reduction of sensitivity and the 
Physical component (r=-0.45; p<0.01); Interpersonal 
problems and the Physical component (r=-0.43; 
p<0.01); Interpersonal problems and the Mental 
component (r=-0.49; p<0.01); Emotional distress and 
the Physical component (r=-0.49; p<0.01), and also 
negative correlations of strong magnitude between 
the domains Diffuse sensory-motor symptoms and the 
Physical component (r=-0.64; p<0.01); Limitations in 
daily activities and the Physical component (r=0.60); 
Emotional distress and the Mental component (r =-0.71; 
p<0.01). The other relationships found between the 
domains of the NeuroQol and the components of the SF-
36 were of low magnitude and therefore of little value 
for clinical practice (Table 4).
*0.01<p<0.05
†p<0.01
The results of the Student’s t test application, 
relative to the discriminant construct validity, are 
presented in Table 5.
NeuroQol
SF 36
Physical 
component 
(PHC)
Mental 
component 
(MHC)
Pain -0.31* -0.41†
Loss/reduction in sensitivity -0.45† -0.26
Diffuse sensory-motor symptoms -0.64† -0.19
Limitations in daily activities -0.60† -0.37†
Interpersonal problems -0.43† -0.49†
Emotional distress -0,49† -0,71†
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Table 5 - Comparison of the standardized mean values  and respective standard deviations for the domains of the 
NeuroQol between the with ulcer and without ulcer groups. Ribeirão Preto, SP, Brazil, 2010
Domains of the NeuroQol
 With ulcer group
p
Without ulcer group 
p
Mean sd Mean sd
Pain 5.6 2.6 0.58 6.0 2.6 0.58
Loss/reduction in sensitivity 7.6 4.6 0.48 6.7 5.0 0.49
Diffuse sensory-motor symptoms 7.9 4.5 0.54 7.1 4.2 0.54
Limitations in daily activities 11.2 4.0 0.00† 7.7 4.0 0.00*
Interpersonal problems 7.5 3.9 0.08 5.5 3.9 0.08
Emotional distress 8.1 4.7 0.67 7.5 4.6 0.67
*p<0.01 Student’s t
It was observed that, when comparing the 
standardized mean values  of the domains of the NeuroQol 
between the with ulcers and without ulcers groups there 
was a difference between the means in the domain of 
Limitations in daily activities, which was expected, since 
people with ulcers have a limited capacity to perform 
their daily activities, such as doing their work, tasks 
in the home or garden, and participating in leisure 
activities, which implies a worse QoL
Discussion
The sample was determined at 50 participants, 
which, according to the literature(16), permits the initial 
evaluation of the psychometric properties of measuring 
instruments for psychosocial variables. In relation to the 
sociodemographic characterization, the sample consisted 
of adults with an mean age of 56 years, low education, 
with a greater frequency of females, similar to those 
of other studies conducted in the same location(21-22), 
which can characterize the profile of people seeking 
medical care in this unit. However, they differ from the 
original construction study of the instrument, developed 
with a population from North America and the United 
Kingdom, in relation to gender and education. Regarding 
the results of the adapted instrument, the highest and 
lowest mean scores were for the domains Limitations in 
daily activities and Pain, respectively, and in the original 
study Loss/reduction of sensitivity and Pain(12). 
Studies indicate that foot ulcers impact in the 
physical functioning of people with diabetes and can 
lead to limitations in daily activities, negatively affecting 
the quality of life(23-24). Although Pain is the lower scoring 
domain in the studies cited, it is present in approximately 
11% of people with DPN, and its presence significantly 
compromises the QoL of people with DM and DPN(25). 
The internal consistency measured by Cronbach’s 
coefficient alpha of the instrument was 0.94, a value 
that can be considered adequate for the validation of 
instruments(16). The domains which obtained the lowest 
and highest values for this coefficient were Pain (0.64) 
and Limitations in daily activities (0.89), respectively. 
Knowing that Cronbach’s alpha values  smaller than 0.70 
can damage the internal consistency(20), it is clarified 
that, in this initial phase of the adaptation and validation 
of the NeuroQol instrument, the sample presented is 
small for the number of items of the instrument, which 
justifies the development of a second phase of the 
study, with a larger number of participants. In relation 
to the floor and ceiling effects, it was observed in the 
present study, that they occurred in the domains Loss/
reduction in sensitivity (16.0) and Limitations in daily 
activities (22.0), respectively. These last psychometric 
analyses of the present study indicate favorable results 
in relation to the expected profile for the distribution 
of responses in a measuring instrument. These effects 
can harm the responsiveness property of the instrument 
that relates to the ability to detect changes when the 
individual improves or worsens(26), that is, the ability of 
the instrument to detect clinically important changes 
with the passage of time(16).
In the convergent validity, the linear correlations 
were negative and statistically significant between all 
the values of the measurements of the components 
of the SF-36 instrument and measurements of the 
domains of the NeuroQol, as expected. While the lower 
SF-36 instrument values  reflect a poorer perception of 
the general health status, in the NeuroQol lower values 
indicate a better QoL. In addition, the results showed 
moderate to strong magnitude correlations between the 
NeuroQol domains and the SF-36, results similar to the 
original study(12). The discriminant validity only showed a 
statistically significant difference between the NeuroQol 
scores of the two groups in the Limitations in daily 
activities domain. The literature states that the presence 
of ulcers can cause greater physical and emotional 
consequences for the person with diabetes than the 
symptoms of the neuropathy(23). Thus, it is expected 
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that the NeuroQol be able to discriminate the greatest 
impact of the disease among people with diabetes and 
ulcers than among those with DM and neuropathy.
Although, the mean scores of the domains, with the 
exception of Pain, were higher among the people with 
ulcers, these differences were not statistically significant 
between the groups studied. For the Pain domain, a 
significantly higher mean was found among those without 
ulcers, which could be explained by the presence of pain 
in the initial stage of the diabetic neuropathy(27). The 
enlargement of the sample size in subsequent studies 
is recommended, in order to expand the analysis of 
discriminant validity between the with and without ulcer 
groups, as well as the performance of the factor analysis 
of the instrument in order to verify the relevance of the 
items in the domains of the instrument in the adapted 
version.
Final considerations
The results of this first phase of adaptation and 
validation allow it to be considered that the NeuroQoL 
has psychometric properties that permit its use as a valid 
and reliable instrument. However, a second phase of the 
study is needed to extend the psychometric evaluation, 
principally with the coverage of different regions of 
Brazil, and to consolidate its cultural adaptation and 
validation. The evaluation of HRQoL is crucial in order 
to establish interventions for the nursing care of people 
with DM. However, it is often necessary to recognize 
the influences of a specific situation of health-illness, 
in order to direct actions to prevent, identify early and 
intervene in health injuries which can compromise the 
biopsychosocial aspects of the person.
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